Stocks · Health care · Pharmaceutical Preparations

CYTOKINETICS INC

CYTK Clue Score32

United States Fiscal year ends December CIK 0001061983 Results filed 4 Nov 2026

Add to watchlist

What the insiders did Net selling

By person

32 insiders · 713 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Robert I Blum

President & CEO

—

$61.02M (229) scheduled

−$61.02M

286,876

0.2064%

$18.05M

+1,034%

Fady Ibraham Malik

EVP Research & Development

—

$33.55M (164) scheduled

−$33.55M

153,902

0.1107%

$9.69M

+1,010%

Bvf Partners L P/Il entity

See Explanaton of Responses

$3.23M (6)

$24.68M (6)

−$21.45M

463,244

0.3332%

$29.15M

−71.5%

Andrew Callos

EVP, Chief Commercial Officer

—

$18.98M (34) scheduled

−$18.98M

58,555

0.0421%

$3.68M

+2,362%

B Lynne Parshall

Director

—

$8.68M (25) scheduled

−$8.68M

10,784

0.0078%

$678.64K

—

Sandford D Smith

Director

—

$6.69M (35) scheduled

−$6.69M

18,801

0.0135%

$1.18M

—

Sung Lee

EVP, Chief Financial Officer

—

$5.70M (5) scheduled

−$5.70M

63,221

0.0455%

$3.98M

—

John T Henderson

Director

$51.43K (1)

$5.75M (19) scheduled

−$5.70M

78,795

0.0567%

$4.96M

+10,519%

Edward M. MD Kaye

Director

—

$5.51M (10) scheduled

−$5.51M

10,629

0.0076%

$668.88K

—

Ching Jaw

SVP Finance & CFO

—

$4.99M (10) scheduled

−$4.99M

57,346

0.0412%

$3.61M

—

David Cragg

Chief HR & Admin Officer

—

$3.80M (10) scheduled

−$3.80M

153,233

0.1102%

$9.64M

+462.6%

Santo J Costa

Director

—

$3.00M (11) scheduled

−$3.00M

20,600

0.0148%

$1.30M

—

Wendall Wierenga

Director

—

$2.88M (12) scheduled

−$2.88M

32,345

0.0233%

$2.04M

—

L Patrick Gage

Director

—

$2.06M (22) scheduled

−$2.06M

28,932

0.0208%

$1.82M

+3.3%

Mark A Schlossberg

SVP - Legal & General Counsel

—

$2.05M (4) scheduled

−$2.05M

103,408

0.0744%

$6.51M

—

Wendell Wierenga

Director

—

$1.88M (3) scheduled

−$1.88M

35,660

0.0257%

$2.24M

+10.2%

Bradley Paul Morgan

SVP Drug Discovery & Early Dev

—

$1.77M (15) scheduled

−$1.77M

46,441

0.0334%

$2.92M

+166.5%

Robert Wong

VP, Chief Accounting Officer

—

$957.58K (4) scheduled

−$957.58K

18,655

0.0134%

$1.17M

+114.5%

Caryn Gordon McDowell

GC & Chief Compliance Officer

—

$574.51K (67) scheduled

−$574.51K

32,548

0.0234%

$2.05M

+415.6%

Robert Arthur Harrington

Director

—

$394.92K (6) scheduled

−$394.92K

22,127

0.0159%

$1.39M

—

Muna Bhanji

Director

—

$215.60K (3) scheduled

−$215.60K

26,361

0.0190%

$1.66M

—

Robert E Landry

Director

—

$146.79K (2) scheduled

−$146.79K

8,184

0.0059%

$515.02K

—

Jeffrey Hessekiel

Chief Legal & Admin Officer

—

—

—

107,943

0.0776%

$6.79M

—

Andrew A Wolff

SVP & CMO

—

—

—

47,255

0.0340%

$2.97M

+91.0%

Elisabeth Schnieders

Sr. VP, Business Development

—

—

—

43,919

0.0316%

$2.76M

+166.4%

Sharon Barbari

EVP, Finance & CFO

—

—

—

40,323

0.0290%

$2.54M

+39.6%

Nancy Wysenski

Director

—

—

—

34,089

0.0245%

$2.15M

—

Brett A Pletcher

EVP, Chief Legal Officer

—

—

—

33,140

0.0238%

$2.09M

—

Bonnie Charpentier

SVP Regulatory & Compliance

—

—

—

29,004

0.0209%

$1.83M

—

Peter S Roddy

SVP Finance & CAO

—

—

—

21,520

0.0155%

$1.35M

+1,316%

Robert Califf

Director

—

—

—

6,003

0.0043%

$377.77K

—

James M Daly

Director

—

—

—

3,585

0.0026%

$225.60K

—